BIOMAT Database Logo BIOMAT Database Logo

Inhibitory effect of reversible serine protease inhibitors on the activity of cytotoxic T lymphocytes. 1989

K Arakawa, and H Nakajima, and T Yoshida, and T Yasumura, and I Aikawa, and Y Ohmori, and T Oka
Second Department of Surgery, Kyoto Prefectural University of Medicine, Japan.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine
D016670 Gabexate A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin. Foy,Gabexate Mesilate,Gabexate Mesylate,Gabexate Methanesulfonate,Gabexate Monomethanesulfonate,Gabexate Monomethanesulfonate, 14C-Labeled Cpd,Gabexate Monomethanesulfonate, 14C Labeled Cpd,Mesilate, Gabexate,Mesylate, Gabexate,Methanesulfonate, Gabexate,Monomethanesulfonate, Gabexate

Related Publications

K Arakawa, and H Nakajima, and T Yoshida, and T Yasumura, and I Aikawa, and Y Ohmori, and T Oka
Serine protease inhibitors and cytotoxic T lymphocytes.
May 2010, Immunological reviews,
K Arakawa, and H Nakajima, and T Yoshida, and T Yasumura, and I Aikawa, and Y Ohmori, and T Oka
Effect of protease inhibitors on angiotensin-converting enzyme activity in human T-lymphocytes.
May 2000, American journal of hypertension,
K Arakawa, and H Nakajima, and T Yoshida, and T Yasumura, and I Aikawa, and Y Ohmori, and T Oka
Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury.
February 2001, Journal of leukocyte biology,
K Arakawa, and H Nakajima, and T Yoshida, and T Yasumura, and I Aikawa, and Y Ohmori, and T Oka
Association of serine protease with the rise of intracellular calcium in cytotoxic T lymphocytes.
December 1996, Cellular immunology,
K Arakawa, and H Nakajima, and T Yoshida, and T Yasumura, and I Aikawa, and Y Ohmori, and T Oka
Transcriptional activation of the human cytotoxic serine protease gene CSP-B in T lymphocytes.
November 1990, Molecular and cellular biology,
K Arakawa, and H Nakajima, and T Yoshida, and T Yasumura, and I Aikawa, and Y Ohmori, and T Oka
A serine protease (CCP1) is sequestered in the cytoplasmic granules of cytotoxic T lymphocytes.
November 1987, Journal of immunology (Baltimore, Md. : 1950),
K Arakawa, and H Nakajima, and T Yoshida, and T Yasumura, and I Aikawa, and Y Ohmori, and T Oka
Serine esterase and hemolytic activity in human cloned cytotoxic T lymphocytes.
February 1988, The Journal of experimental medicine,
K Arakawa, and H Nakajima, and T Yoshida, and T Yasumura, and I Aikawa, and Y Ohmori, and T Oka
Effect of hyperthermia on the functional activity of cytotoxic T-lymphocytes.
October 1977, Journal of the National Cancer Institute,
K Arakawa, and H Nakajima, and T Yoshida, and T Yasumura, and I Aikawa, and Y Ohmori, and T Oka
The isolation and characterization of a family of serine protease genes expressed in activated cytotoxic T lymphocytes.
March 1988, Immunological reviews,
K Arakawa, and H Nakajima, and T Yoshida, and T Yasumura, and I Aikawa, and Y Ohmori, and T Oka
[Effect of thymic hormonal factors on the serine protease activity of splenic and thymic lymphocytes].
November 1984, Vrachebnoe delo,
Copied contents to your clipboard!